ASA Biopharm's Podcast

In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.

http://community.amstat.org/BioP/Home/

Eine durchschnittliche Folge dieses Podcasts dauert 44m. Bisher sind 108 Folge(n) erschienen. Dieser Podcast erscheint alle 4 Wochen.

Gesamtlänge aller Episoden: 3 days 2 hours 4 minutes

subscribe
share






Episode 47: Pediatric Medical Product Development


Susan Wang and Amy Xia discuss the challenges of pediatric medical product development.


share








 November 6, 2017  45m
 
 

Episode 46: Re-Randomization of Subjects Scientific Working Group


Gheorghe Doros, Anastasia Ivanova, and George Papakostas discuss the Sequential Parallel Comparison Design and the newly-formed Clinical Trial Designs with Re-Randomization of Subjects Scientific Working Group.


share








 October 15, 2017  53m
 
 

Episode 45: Kelly Zou


Kelly shares her thoughts on real world data and real world evidence in the healthcare and pharmaceutical industry.


share








 September 19, 2017  24m
 
 

Episode 44: Weili He and Martin Ho


Weili and Martin discuss the 2017 Regulatory-Industry Statistics Workshop.


share








 August 17, 2017  35m
 
 

Episode 43: 40th Anniversary of PSI


Andy Grieve, Nigel Howitt, John Lewis and Lucy Rowell reminisce about PSI’s past and look forward to its future.


share








 July 27, 2017  47m
 
 

Episode 42: Committee on Minorities in Statistics


Reneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.


share








 June 29, 2017  47m
 
 

Episode 41: Liz Stuart


Liz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.


share








 June 5, 2017  42m
 
 

Episode 40: Estimands


Yuki Ando, Frank Bretz, Rob Hemmings and Tom Permutt discuss estimands and the ICH E9 revisions.


share








 May 8, 2017  56m
 
 

Episode 39: Alex Dmitrienko


Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.


share








 March 14, 2017  58m
 
 

Episode 39: Alex Dmitrienko


Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.


share








 March 14, 2017  58m